AUG 18, 2019 6:21 PM PDT

Could electromagnetic fields treat metastatic triple-negative breast cancer?

New research published in Communications Biology suggests that electromagnetic fields are capable of stopping the metastasis of some breast cancer cells. In the study, researchers showed that they are able to target migrating breast cancer cells using a tool called a Helmholtz coil, which was developed by scientists at Ohio State University.

While the research has yet to be conducted in human clinical trials, lead author Jonathan Song says that the tool mimics "what actually happens in the body in a controllable environment." Song is an assistant professor of mechanical and aerospace engineering at Ohio State University.

New research uses electromagnetic fields to target breast cancer cells. Photo: Pixabay

Combining the coil along with another instrument capable of monitoring the direction of cell movement via a microscope, Song and his colleagues figured out how energy from electromagnetic fields affected the shape and movement of the cancer cells.

"What we showed, biologically, is that these cancer cells are becoming profoundly less metastatic, which is a very important finding," said Song.

The most significant conclusion from the exposure of cancer cells to electromagnetic fields was regarding its impact on metastatic triple-negative breast cancer cells. This type of breast cancer cells are the most difficult to treat because they don’t have estrogen or progesterone receptors or human epidermal growth factor receptor 2 genes, which are the receptors that many cancer treatments target. What is exciting is that this type of cancer cells was the most responsive to electromagnetic fields.

The researchers also determined that using electromagnetic energy in combination with specific drug therapies — particularly those that target cell growth signals carried by the AKT protein — could have better results. Nevertheless, in order for this method to be used as a cancer treatment option, more research will be needed, including animal and human clinical trials.

Sources: Medical News TodayCommunications Biology

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
AUG 30, 2021
Cancer
A Hot Approach to CAR T Cells
AUG 30, 2021
A Hot Approach to CAR T Cells
Immunotherapy, a type of treatment that targets a patient’s immune system to enhance the natural ability to attack ...
AUG 29, 2021
Cancer
Researchers Bioprint Deadly Brain Tumor with 3D Printer
AUG 29, 2021
Researchers Bioprint Deadly Brain Tumor with 3D Printer
Researchers have managed to print an entire active and viable glioblastoma tumor- the deadliest form of brain cancer- us ...
SEP 13, 2021
Cancer
Fat Loss can Predict Gastric Cancer Survival
SEP 13, 2021
Fat Loss can Predict Gastric Cancer Survival
Cancer cachexia is a metabolic disorder in cancer patients experiencing uncontrolled weight loss.  While cancer cac ...
SEP 20, 2021
Cancer
An Established Ovarian Cancer Antigen Presents a Promising Therapeutic Target
SEP 20, 2021
An Established Ovarian Cancer Antigen Presents a Promising Therapeutic Target
For the past several decades, cancer antigen 125 (CA 125), a protein located on the surface of ovarian cancer cells, has ...
OCT 04, 2021
Cancer
Good News for Coffee Lovers: A New Study Finds Caffeine Does Not Impact Breast Cancer Risk
OCT 04, 2021
Good News for Coffee Lovers: A New Study Finds Caffeine Does Not Impact Breast Cancer Risk
Reports indicate that caffeine consumption in the United States is greatest in adults aged 50 – 64.  Coincide ...
JAN 24, 2022
Microbiology
Potential Anti-Cancer Bacterium Found in Antarctic Sea Squirt
JAN 24, 2022
Potential Anti-Cancer Bacterium Found in Antarctic Sea Squirt
Some of our best medicine has come from nature, and scientists are always on the lookout for natural products that can b ...
Loading Comments...